Pay in 4 interest-free payments of $6.90 Learn more
Ships within 48 hours · Estimated delivery Aug 25 - Aug 30
They can last for several years, depending on the type, and do not require daily attention like taking a pill
Clinical trials involving 469 adults demonstrated its efficacy in treating moderate to severe OSA, particularly in individuals with obesity
Evidence of stratification and atypia of biliary epithelial component is minimal or absent
Additionally, topiroxostat inhibits the ATP-binding cassette transporter G2 (ABCG2), which plays a key role in renal uric acid reabsorption and the secretion of uric acid from the intestines
Throughout 20242025, major biotech deals reshaped the landscape: Roche/Zealand (Dec 2024) A Reuters report announced Roche would pay $1.65B upfront (up to $5.3B including milestones) for rights to Zealand Pharmas amylin analog petrelintide , testing in obesity ( [13] )
US$ 20.52
US$ 22.77
US$ 25.30
US$ 24.20
US$ 26.45
US$ 22.58
US$ 27.51
US$ 20.50
US$ 27.69
US$ 27.52
US$ 23.89
US$ 21.50
